Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
- PMID: 32469871
- PMCID: PMC7259639
- DOI: 10.1371/journal.pone.0232785
Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
Erratum in
-
Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.PLoS One. 2020 Jul 14;15(7):e0236379. doi: 10.1371/journal.pone.0236379. eCollection 2020. PLoS One. 2020. PMID: 32663228 Free PMC article.
Abstract
Background: Alzheimer's disease (AD) pathology precedes symptoms and its detection can identify at-risk individuals who may benefit from early treatment. Since the retinal nerve fiber layer (RNFL) is depleted in established AD, we tested whether its thickness can predict whether cognitively healthy (CH) individuals have a normal or pathological cerebrospinal fluid (CSF) Aß42 (A) and tau (T) ratio.
Methods: As part of an ongoing longitudinal study, we enrolled CH individuals, excluding those with cognitive impairment and significant ocular pathology. We classified the CH group into two sub-groups, normal (CH-NAT, n = 16) or pathological (CH-PAT, n = 27), using a logistic regression model from the CSF AT ratio that identified >85% of patients with a clinically probable AD diagnosis. Spectral-domain optical coherence tomography (OCT) was acquired for RNFL, ganglion cell-inner plexiform layer (GC-IPL), and macular thickness. Group differences were tested using mixed model repeated measures and a classification model derived using multiple logistic regression.
Results: Mean age (± standard deviation) in the CH-PAT group (n = 27; 75.2 ± 8.4 years) was similar (p = 0.50) to the CH-NAT group (n = 16; 74.1 ± 7.9 years). Mean RNFL (standard error) was thinner in the CH-PAT group by 9.8 (2.7) μm; p < 0.001. RNFL thickness classified CH-NAT vs. CH-PAT with 87% sensitivity and 56.3% specificity.
Conclusions: Our retinal data predict which individuals have CSF biomarkers of AD pathology before cognitive deficits are detectable with 87% sensitivity. Such results from easy-to-acquire, objective and non-invasive measurements of the RNFL merit further study of OCT technology to monitor or screen for early AD pathology.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- 2019 Alzheimer's disease facts and figures. Alzheimers Dement. 2019;15(3):321–87.
-
- Batsch NL, Mittelman MS, eds. World Alzheimer Report 2012: Overcoming the Stigma of Dementia. Ldon: Alzheimer’s Disease International; 2012:75.
-
- Uhlmann RF, Larson EB, Koepsell TD, Rees TS, Duckert LG. Visual impairment and cognitive dysfunction in Alzheimer’s disease. J Gen Intern Med. 1991;6:126–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
